- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16.10. | FDA set to decide on GSK's gepotidacin antibiotic in March | ||
| 16.10. | MeiraGTx plans to take Parkinson's gene therapy into phase 3 | ||
| 16.10. | Pfizer sticks $1.5bn on Triana's molecular glue tech | ||
| 16.10. | GSK turns its guns on Moderna in mRNA jab patent dispute | ||
| 15.10. | US digital health spending set to increase, survey finds | ||
| 15.10. | LEO launches chronic hand eczema drug in its first market | ||
| 15.10. | Transgene cervical cancer shot misses the mark in phase 2 | ||
| 15.10. | Lundbeck drops in on epilepsy drug with $2.6bn Longboard bid | ||
| 15.10. | Lilly pledges £279m to UK for biotech hub and obesity plan | ||
| 14.10. | CEPI-backed trial of Rift Valley fever jab starts in Kenya | ||
| 14.10. | GSK asthma hope depemokimab works in second indication | ||
| 14.10. | Baxter medicines in short supply after hurricane hits plant | ||
| 14.10. | FDA rethinking block on compounding of Lilly's obesity drug | ||
| 14.10. | Pfizer rounds out haemophilia portfolio with FDA approval | ||
| 11.10. | Sanofi in talks to sell stake in consumer health spinout | ||
| 11.10. | Roche gets FDA green light for breast cancer drug Itovebi | ||
| 11.10. | Lawmaker asks FTC to probe Novo/Catalent deal | ||
| 11.10. | Starboard claims Pfizer 'threatened' former leaders | ||
| 10.10. | EVERSANA partners Oracle on pharmacovigilance platform | ||
| 10.10. | Ono, Boehringer add to cancer pipelines with licensing deals | ||
| 10.10. | UK celeb seeks funds to challenge NICE's Enhertu verdict | ||
| 10.10. | City Therapeutics' $135m debut, and other bio financing news | ||
| 10.10. | Ex-Pfizer leaders side with firm against activist investor | ||
| 10.10. | GSK says $2.2bn settlement resolves most Zantac litigation | ||
| 09.10. | FDA knocks back Zealand's dasiglucagon once again |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
